FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 14, Pages 1845-1858
Publisher
Springer Nature
Online
2011-08-23
DOI
10.1038/onc.2011.368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
- (2012) Dariusz Pytel et al. Anti-Cancer Agents in Medicinal Chemistry
- Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
- (2011) Ana R. Gomes et al. CELL CYCLE
- Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
- (2010) Roque Diaz et al. BMC CANCER
- Structure of the FoxM1 DNA-recognition domain bound to a promoter sequence
- (2010) D. R. Littler et al. NUCLEIC ACIDS RESEARCH
- Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma
- (2010) Kondo ONCOLOGY REPORTS
- Angiogenesis and Lymphangiogenesis of Gastric Cancer
- (2010) Yasuhiko Kitadai Journal of Oncology
- Foxo1 is essential for in vitro vascular formation from embryonic stem cells
- (2009) Seung-Hwan Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- VEGFs and receptors involved in angiogenesis versus lymphangiogenesis
- (2009) Marja Lohela et al. CURRENT OPINION IN CELL BIOLOGY
- The role of angiogenesis in solid tumours: An overview
- (2009) Nektaria Makrilia et al. European Journal of Internal Medicine
- FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol
- (2009) Rakesh K. Srivastava et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
- (2009) L. Jain et al. MOLECULAR CANCER THERAPEUTICS
- Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
- (2009) U. B. McGovern et al. MOLECULAR CANCER THERAPEUTICS
- BH3-only protein Bim more critical than Puma in tyrosine kinase inhibitor-induced apoptosis of human leukemic cells and transduced hematopoietic progenitors carrying oncogenic FLT3
- (2008) A. Nordigarden et al. BLOOD
- FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells
- (2008) Yujian Zhang et al. CANCER RESEARCH
- VEGFPolymorphisms and Survival in Early-Stage Non–Small-Cell Lung Cancer
- (2008) Rebecca Suk Heist et al. JOURNAL OF CLINICAL ONCOLOGY
- The Forkhead Transcription Factor FOXO3a Increases Phosphoinositide-3 Kinase/Akt Activity in Drug-Resistant Leukemic Cells through Induction of PIK3CA Expression
- (2008) R. C.-Y. Hui et al. MOLECULAR AND CELLULAR BIOLOGY
- FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells
- (2008) Silvia Fernández de Mattos et al. MOLECULAR CANCER THERAPEUTICS
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
- Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells
- (2008) R. C-Y. Hui et al. MOLECULAR CANCER THERAPEUTICS
- S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons
- (2008) Alexi Nott et al. NATURE
- A brief introduction to FOXOlogy
- (2008) B M Th Burgering ONCOGENE
- FOXO animal models reveal a variety of diverse roles for FOXO transcription factors
- (2008) K C Arden ONCOGENE
- The FoxO code
- (2008) D R Calnan et al. ONCOGENE
- Many forks in the path: cycling with FoxO
- (2008) K K Ho et al. ONCOGENE
- FOXOs, cancer and regulation of apoptosis
- (2008) Z Fu et al. ONCOGENE
- OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins
- (2008) Kenneth Maiese et al. TRENDS IN MOLECULAR MEDICINE
- FOXO3a Turns the Tumor Necrosis Factor Receptor Signaling Towards Apoptosis Through Reciprocal Regulation of c-Jun N-Terminal Kinase and NF-κB
- (2007) Hae-Young Lee et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More